Q1 EPS Estimates for Stoke Therapeutics Lowered by Wedbush
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Wedbush dropped their Q1 2025 earnings estimates for shares of Stoke Therapeutics in a report released on Wednesday, February 19th. Wedbush analyst L. Chico now expects that the company will post earnings of ($0.58) per share for the quarter, down from their previous estimate of ($0.56). The […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Wedbush dropped their Q1 2025 earnings estimates for shares of Stoke Therapeutics in a report released on Wednesday, February 19th. Wedbush analyst L. Chico now expects that the company will post earnings of ($0.58) per share for the quarter, down from their previous estimate of ($0.56). The […]
